# FDA Inspection 823272 - LaCrosse Cryobank - March 20, 2013

Source: https://www.keypedia.com/records/fda_inspections/lacrosse-cryobank/1fcfdd0e-0908-4e85-95c9-befe1624a083
Source feed: FDA_Inspections

> FDA Inspection 823272 for LaCrosse Cryobank on March 20, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 823272
- Company Name: LaCrosse Cryobank
- Inspection Date: 2013-03-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 705120 - 2011-01-07](https://www.keypedia.com/records/fda_inspections/lacrosse-cryobank/5486c4f2-b284-4869-82cf-3b5b1cee61d3)
- [FDA Inspection 596985 - 2009-07-15](https://www.keypedia.com/records/fda_inspections/lacrosse-cryobank/b9d100a9-c99b-4595-a0ec-1b1e2cb4443f)
- [FDA Inspection 596985 - 2009-07-15](https://www.keypedia.com/records/fda_inspections/lacrosse-cryobank/303ab025-593e-435b-b261-80f9d5cc09a5)

Company: https://www.keypedia.com/companies/lacrosse-cryobank/989ecee2-3610-42e8-a457-a01e29783028

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d